Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease
AbstractAutosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by the development of fluid-filled cysts in the kidneys. The primary cause of ADPKD is mutations in the PKD1 (polycystic kidney disease 1) or PKD2 (polycystic kidney disease 2) gene. Patients with ADP...
Main Authors: | Jinjun Zhu, Fei Liu, Jianhua Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2282027 |
Similar Items
-
Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
by: Sans-Atxer L, et al.
Published: (2018-01-01) -
The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function
by: Cuma Bulent Gul, et al.
Published: (2021-01-01) -
Autosomal Dominant Polycystic Kidney Disease: Review and Management Update
by: Víctor Martínez
Published: (2014-07-01) -
Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
by: Dorothee Oberdhan, et al.
Published: (2024-01-01) -
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2023-02-01)